VERA veratx.com: Bozor qiymatining balans qiymatiga nisbati
Vera Therapeutics, Inc. (VERA) kompaniyasining investitsiya profili, kapital bazasi to'ldirilganiga qaramay, ataciceptning yakuniy sinovlari atrofidagi noaniqliklar va operatsion yo'qotishlar tufayli og'irlashgan. Vera Therapeutics, Inc. (VERA) nefrologiyadagi inqilobiy yutuqlarga tayanib, IgA nefropatiyasi terapiyasi segmentida ustunlikka erishishni maqsad qilgan. Ushbu narxlar grafigi 5.49 qiymatga ega bo'lgan aktivning dinamikasini aks ettiradi. Biznes kengroq iqtisodiy tendentsiyalardan mustaqil qolmoqda, chunki uning taqdiri ilmiy yutuqlarga va R&D moliyalashtirish imkoniyatlariga bog'liq.
Vera Therapeutics Inc (VERA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Vera Therapeutics, Inc.|VERA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Vera Pharma|VERA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Vera Pharma|VERA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Vera Therapeutics|Tezkor likvidlik koeffitsiyenti veratx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Vera Therapeutics, Inc. - VERA
Fundamental jihatdan barqaror aktivlarni aniqlash uchun investorlar bozor qiymatining buxgalteriya qiymatiga nisbatidan foydalanadilar, bu ko'rsatkich kompaniyaning sof aktivlariga nisbatan bozor baholash premiumsini belgilaydi. Bozor qiymatining buxgalteriya qiymatiga nisbatidagi o'zgarishlarni tahlil qilish orqali Vera Therapeutics, Inc. (VERA) kompaniyasining haddan tashqari yuqori baholanganligini aniqlash mumkin, uning immunoterapiya ishlanmalari hozirda logistika va klinik sinovlardagi geosiyosiy uzilishlar tufayli zaif holatda qolmoqda.
Raqobatchilar tahlili
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|biontech.de (BNTX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|DNTH (Dianthus Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pharvaris.com|Kapitallashuvning sof aktivlarga nisbati ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PGEN (Intrexon)|Balans qiymatiga nisbatan bozor kapitallashuvi Pharming Corp (PHAR)|NKTR - Bozor qiymatining balans qiymatiga nisbati|upstreambio.com (UPB) - Kapitallashuvning sof aktivlarga nisbati|Zenas Biopharma (ZBIO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|Kapitallashuvning sof aktivlarga nisbati GOSS|Bozor kapitallashuvining balans qiymatiga nisbati KalVista Corp|Bozor qiymatining balans qiymatiga nisbati Septerna Inc (SEPN)|pieris.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SVRA (Savara)|Rigel Pharma (RIGL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ANAB: Kapitallashuvning sof aktivlarga nisbati|ATXS: Bozor qiymatining balans qiymatiga nisbati|ENGN: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti rapt.com (RAPT)|Bozor qiymatining balans qiymatiga nisbati Aerovate Therapeutics, Inc.|ACRS: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KYTX|Bozor kapitallashuvining balans qiymatiga nisbati Tiziana Life Sciences, Ltd. (TLSA)|Cabaletta Bio, Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati VTYX|THTX: Kapitallashuvning sof aktivlarga nisbati|Avalo Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|ELDN: Bozor kapitallashuvining balans qiymatiga nisbati|Agenus, Inc - Balans qiymatiga nisbatan bozor qiymati|CLYM (Climb Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti zurabio.com ZURA|Bozor qiymatining balans qiymatiga nisbati aTyr Pharma (ATYR)|ADAG (adagene.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Bozor kapitallashuvining balans qiymatiga nisbati Shattuck Labs Inc STTK|EQ - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CNTB|IMUX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Atara Bio (ATRA)|Kapitallashuvning sof aktivlarga nisbati IFRX|Bozor kapitallashuvining balans qiymatiga nisbati X4 Pharmaceuticals, Inc|Kapitallashuvning sof aktivlarga nisbati ACET (Adicet Bio)|Bozor kapitallashuvining balans qiymatiga multiplikatori CELU|Bozor kapitallashuvining balans qiymatiga nisbati INMB (INmune Bio)|Balans qiymatiga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC (BRNS)|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Kapitallashuvning sof aktivlarga nisbati|Akari Therapeutics (AKTX) - Bozor qiymatining balans qiymatiga nisbati|ENLV - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati QTTB|GOVX: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|XTLB: Kapitallashuvning balans qiymatiga nisbati|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|HCW Biologics Inc. (HCWB) - Kapitallashuvning sof aktivlarga nisbati|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|AIM - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati ADTX|Bozor qiymatining balans qiymatiga nisbati GRI|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|HIND - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|Balans qiymatiga nisbatan bozor qiymati INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CALI - Bozor kapitallashuvining balans qiymatiga nisbati|affimed.com (AFMD) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ALLK (Allakos)|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati oceanbiomedical.com (OCEA)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|Balans qiymatiga nisbatan bozor qiymati THRD